| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8439316 | European Journal of Cancer | 2018 | 9 Pages |
Abstract
Our survey found that exceptional responders tended to have solid organ malignancies and most received targeted therapies. Many of our cases of exceptional responders were missing important information about the response and key oncologic history. Standardised criteria should be used to maximise usefulness of these case reports in the future.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Go Nishikawa, Jia Luo, Vinay Prasad,